Quick Answer
KYNTRA BIO, INC. reported Common Stock Shares Outstanding of 4.05 million shares for the year ending 2025.
- KYNTRA BIO, INC. showed an increase of +0.2% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from KYNTRA BIO, INC.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 12 years of available data (2014 to 2025), KYNTRA BIO, INC.'s Common Stock Shares Outstanding has declined by 93.1%.
- Historical annual values: Fiscal year 2025: 4.05 million shares | Fiscal year 2024: 4.04 million shares | Fiscal year 2023: 98.77 million shares | Fiscal year 2022: 94.17 million shares | Fiscal year 2021: 92.88 million shares | Fiscal year 2020: 91.44 million shares | Fiscal year 2019: 87.66 million shares | Fiscal year 2018: 85.43 million shares | Fiscal year 2017: 82.50 million shares | Fiscal year 2016: 63.67 million shares | Fiscal year 2015: 61.99 million shares | Fiscal year 2014: 59.05 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: